flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the FLOW trial Ozempic® (semaglutide injection)

As the understanding of obesity as a metabolic disease continues to evolve, so too will the strategies for managing weight regain after VSG

If you believe you're experiencing side effects from your medication, you can report them through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)

They also highlight a recurring pattern in peptide drug development: early safety signals, particularly those observed at supraphysiologic exposure levels or in non-human models, have frequently led to premature abandonment of otherwise biologically compelling targets

GhoshSLertwattanarakRGardunoJJGaleanaJJLiJZamarripaFet al

If side effects persist beyond two months, inform your prescriberdosing adjustments or temporary pause may help

Big Apple Medical Care monitors patients for signs of hypoglycemia, especially those taking other diabetes medications